Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial.
Michelle SholzbergGrace H TangHassan RahhalMusaad AlHamzahLisa Baumann KreuzigerFionnuala Ní ÁinleFaris AlomranKhalid AlayedMohammed AlsheefFahad AlSumaitCarlos Eduardo PompilioCatherine SperlichSabrena TangriTerence TangPeter JaksaDeepa SuryanarayanMozah AlmarshoodiLana A CastellucciPaula D JamesDavid LillicrapMarc CarrierAndrew BeckettChristos ColovosJai JayakarMarie-Pier ArsenaultCynthia WuKarine DoyonE Roseann AndreouVera DounaevskaiaEric K TsengGloria LimMichael FralickSaskia MiddeldorpAgnes Y Y LeeFei ZuoBruno R da CostaKevin E ThorpeElnara Márcia NegriMary CushmanPeter Jüninull nullPublished in: BMJ (Clinical research ed.) (2021)
ClinicalTrials.gov NCT04362085.
Keyphrases
- mechanical ventilation
- clinical trial
- intensive care unit
- venous thromboembolism
- acute respiratory distress syndrome
- open label
- double blind
- growth factor
- study protocol
- randomized controlled trial
- phase ii
- respiratory failure
- emergency department
- systematic review
- healthcare
- acute care
- adverse drug
- loop mediated isothermal amplification
- extracorporeal membrane oxygenation
- placebo controlled
- sensitive detection